EUVIMEDEUVIMED entdecken
Open Access

CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification

Afam A Okoye, Derick D Duell, Yoshinori Fukazawa, Benjamin Varco-Merth, Alejandra Marenco, Hannah Behrens, Morgan Chaunzwa, Andrea N Selseth, Roxanne M Gilbride, Jason Shao, Paul T Edlefsen, Romas Geleziunas und 12 weitere

Journal of Clinical Investigation · 15.04.2021 · 131 (8)

DOI: 10.1172/jci141677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.04.2021. Verfasst von Afam A Okoye und 23 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Gene Therapy Institute and. Hauptthemen laut MEDLINE: Lymphocyte Depletion. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocyte DepletionAnimalsAnti-Retroviral AgentsCD8-Positive T-LymphocytesFemaleMacaca mulattaMaleSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusVirus Activation

Stichwörter der Autor:innen

AIDS/HIVAdaptive immunityT cells

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Vaccine and Gene Therapy Institute and.
  • Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
  • Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Gilead Sciences, Inc., Foster City, California, USA.
  • Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, New South Wales, Australia.
  • AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NIAID NIH HHS
  • CCR NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIH Office of the Director
  • National Cancer Institute

Zitieren

APA

Okoye, A. A., Duell, D. D., Fukazawa, Y., Varco-Merth, B., Marenco, A., Behrens, H., Chaunzwa, M., Selseth, A. N., Gilbride, R. M., Shao, J., Edlefsen, P. T., Geleziunas, R., Pinkevych, M., Davenport, M. P., Busman-Sahay, K., Nekorchuk, M., Park, H., Smedley, J., Axthelm, M. K., …, & Picker, L. J. (2021). CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. Journal of Clinical Investigation, 131(8). https://doi.org/10.1172/jci141677

Vancouver

Okoye AA, Duell DD, Fukazawa Y, Varco-Merth B, Marenco A, Behrens H, et al. CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification. Journal of Clinical Investigation. 2021;131(8). doi:10.1172/jci141677

BibTeX
@article{Okoye2021,
  author = {Okoye, Afam A and Duell, Derick D and Fukazawa, Yoshinori and Varco-Merth, Benjamin and Marenco, Alejandra and Behrens, Hannah and Chaunzwa, Morgan and Selseth, Andrea N and Gilbride, Roxanne M and Shao, Jason and Edlefsen, Paul T and Geleziunas, Romas and Pinkevych, Mykola and Davenport, Miles P and Busman-Sahay, Kathleen and Nekorchuk, Michael and Park, Haesun and Smedley, Jeremy and Axthelm, Michael K and Estes, Jacob D and Hansen, Scott G and Keele, Brandon F and Lifson, Jeffery D and Picker, Louis J},
  title = {CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  volume = {131},
  number = {8},
  doi = {10.1172/jci141677}
}
Kostenlos starten →